Sign in

Liora Katz

@likatz.bsky.social
243 followers 113 following 7 posts

Associate Professor Diabetes, obesity and metabolism institute Mount Sinai, NY

PostsRepliesMedia
Liora Katz @likatz.bsky.social · 10/10/2025
Excited to share our Commentary in JCI. Exploring how SIRT2 regulates human beta cell proliferation www.jci.org/articles/vie... @jci.org
jci.org
JCI - SIRT2 puts the brakes on human β cell proliferation: therapeutic opportunities and next challenges
032
Reposted by Liora Katz
Denis Wirtz @deniswirtz.bsky.social · 13/03/2025
NIH is the best investment there is. www.forbes.com/sites/michae...
forbes.com
NIH Grants Fueled $95 Billion In FY 2024 Economic Activity, Finds New Report
National Institutes of Health grants generated almost $95 billion in economic activity nationwide in FY 2024 according to a new report by United for Medical Research.
5267132
Reposted by Liora Katz
Daniel Drucker @danieljdrucker.bsky.social · 02/03/2025
A molecular glue’ compound led to potent ChREBPα/14-3-3 PPI stabilization, retained ChREBPα in the cytoplasm, and efficiently protected β-cells from glucolipotoxicity while maintaining β-cell identity. @naturecomms.bsky.social www.nature.com/articles/s41...
nature.com
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity - Nature Communications
Targeting transcription factors with small molecules remains a significant challenge in drug discovery. Here, the authors present a structure-based approach to stabilize ChREBPα/14-3-3 interactions, s...
042
Liora Katz @likatz.bsky.social · 02/03/2025
Excited to share our work in @naturecomms.bsky.social We shows that molecular glues of the ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity. This could lead to new treatments for Diabetes by preserving beta cell function. www.nature.com/articles/s41... #DiabetesResearch #BetaCells
nature.com
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity - Nature Communications
Targeting transcription factors with small molecules remains a significant challenge in drug discovery. Here, the authors present a structure-based approach to stabilize ChREBPα/14-3-3 interactions, s...
0115
Reposted by Liora Katz
Margaret Echelbarger @bskybymidge.bsky.social · 27/02/2025
✨NYC Stand Up for Science Rally: March 7 (12-3pm)✨ This event is a call to protect publicly funded science from political interference and to reaffirm that diversity, equity, inclusion, and access are essential to scientific progress. @standupforscience.bsky.social (permit pending for location)
Flyer for NYC Stand Up for Science Rally: March 7, 2025, Washington Square Park, 12-3pm. The flyer also reads: Science is for everyone. Find your local rally site and other ways to get involved: standupforscience2025.org. A blue Statue of Liberty is included on the left.
06829
Liora Katz @likatz.bsky.social · 23/01/2025
Making America great means supporting research that saves lives, improves health, and drives new technology. Freezing NIH funding hurts all of us. Let’s tell our leaders to INCREASE funding for the NIH and keep America at the forefront of science and innovation!
031
Liora Katz @likatz.bsky.social · 05/01/2025
Happy to be a part of this amazing interdiciplinary reseach group!
130
Reposted by Liora Katz
Women in TPD & Induced Proximity @womenintpd.bsky.social · 22/11/2024
New work led by Liora Katz at Mt. Sinai along with colleagues of a non-degrading molecular glue between a TF (ChREBP) and a 14-3-3 protein which effectively traps the TF in the nucleus, thereby preventing activation of its target genes in the nucleus. Congratulations! www.biorxiv.org/content/10.1...
biorxiv.org
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity
The Carbohydrate Response Element Binding Protein (ChREBP) is a glucose-responsive transcription factor (TF) with two major splice isoforms (α and β). In chronic hyperglycemia and glucolipotoxicity, C...
121